The CRISPR pioneer Feng Zhang spoke with Insider about Aera Therapeutics, his Boston-based biotech. On Thursday, the company said it has raised $193 million in a combined Series A and Series B ...

Feng Zhang’s year-old CRISPR delivery startup Aera lays off quarter of staff. By Jason Mast Jan. 4, 2024. Reprints. Aera was formed to pursue a nanoparticle described by Feng Zhang in 2021.

CRISPR pioneer Feng Zhang launches new genetic delivery startup with $193 million. By Allison DeAngelis Feb. 16, 2023. Reprints. Feng Zhang Aera Therapeutics.

While there may be exotic CRISPR systems hidden in these libraries, there are simply too many entries to search. This month, a team at MIT and Harvard led by CRISPR pioneer Dr. Feng Zhang took ...

At a time when CRISPR companies have struggled, the Feng Zhang spinoff Arbor Biotechnologies gets a lifeline to head to clinical trials. Skip to Main Content Manage alerts for this article ...

Additional significant contributors to the development of CRISPR-Cas9 include Feng Zhang and David Liu. ... Using the CRISPR screening technique combined with single-cell sequencing, ...

The U.S. Secretary of Health and Human Services recommended including SCID in the screening panel in 2010, ... Feng Zhang. Zhang is an innovator in CRISPR and optogenetics whose solutions in ...

A keynote lecture from Feng Zhang, PhD (Broad Institute) on precision genome editing with and without CRISPR. Beth Shapiro, PhD (Colossal Biosciences) discusses gene editing milestones, de ...

The core components of CRISPR-based genome-editing therapies are bacterial proteins called nucleases that can stimulate unwanted immune responses in people, ... The study was led by Feng Zhang, ...